We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+9.49%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$18B
AUM Growth
+$1.33B
Cap. Flow
-$21.1M
Cap. Flow %
-0.12%
Top 10 Hldgs %
31.84%
Holding
342
New
16
Increased
129
Reduced
153
Closed
4

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$90.3M
2
DELL icon
Dell
DELL
+$77.6M
3
CME icon
CME Group
CME
+$75.1M
4
GD icon
General Dynamics
GD
+$44.2M
5
PPL
PPL Corp
PPL
+$30.7M

Top Sells

Rank Stock Value
1
RF icon
Regions Financial
RF
+$62.2M
2
AVGO icon
Broadcom
AVGO
+$59.8M
3
ES icon
Eversource Energy
ES
+$36.2M
4
APD icon
Air Products & Chemicals
APD
+$28.1M
5
UNH icon
UnitedHealth
UNH
+$27.1M

Sector Composition

Rank Sector Weight
1 Technology 22.45%
2 Healthcare 14.96%
3 Financials 13.98%
4 Industrials 12.12%
5 Consumer Staples 11.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
G icon
201
Genpact
G
$5.76B
$2.4M 0.01%
72,942
-37,177
-34% -$1.29M
VIGI icon
202
Vanguard International Dividend Appreciation ETF
VIGI
$9.3B
$2.38M 0.01%
29,210
+7,027
+32% +$563K
SHEL icon
203
Shell
SHEL
$245B
$2.34M 0.01%
34,850
LYB icon
204
LyondellBasell Industries
LYB
$19.2B
$2.1M 0.01%
20,487
-668
-3% -$65K
EOG icon
205
EOG Resources
EOG
$70.7B
$2.09M 0.01%
16,356
-1,244
-7% -$145K
PFE icon
206
Pfizer
PFE
$153B
$2.08M 0.01%
74,945
-7,046
-9% -$196K
PM icon
207
Philip Morris
PM
$295B
$2.03M 0.01%
22,162
+1,191
+6% +$110K
KMB icon
208
Kimberly-Clark
KMB
$36.5B
$1.99M 0.01%
15,358
-4
-0% -$491
AIT icon
209
Applied Industrial Technologies
AIT
$13.3B
$1.98M 0.01%
10,000
WST icon
210
West Pharmaceutical
WST
$24.9B
$1.97M 0.01%
4,976
+2,050
+70% +$758K
TMO icon
211
Thermo Fisher Scientific
TMO
$220B
$1.94M 0.01%
3,331
+40
+1% +$22.4K
GPC icon
212
Genuine Parts
GPC
$18.7B
$1.89M 0.01%
12,170
+12
+0.1% +$1.75K
DEO icon
213
Diageo
DEO
$53.6B
$1.84M 0.01%
12,347
-220
-2% -$32.2K
CL icon
214
Colgate-Palmolive
CL
$74.4B
$1.82M 0.01%
20,217
-750
-4% -$63.5K
A icon
215
Agilent Technologies
A
$41.2B
$1.78M 0.01%
12,255
-4,450
-27% -$610K
GIS icon
216
General Mills
GIS
$19.7B
$1.74M 0.01%
24,881
+2,321
+10% +$151K
AMT icon
217
American Tower
AMT
$80.4B
$1.72M 0.01%
8,722
-2,301
-21% -$458K
SCL icon
218
Stepan Co
SCL
$1.48B
$1.66M 0.01%
18,398
-28
-0.2% -$2.51K
STE icon
219
Steris
STE
$23.1B
$1.65M 0.01%
7,334
-350
-5% -$78.9K
CAT icon
220
Caterpillar
CAT
$387B
$1.65M 0.01%
4,497
+25
+0.6% +$7.99K
WPC icon
221
W.P. Carey
WPC
$16.4B
$1.64M 0.01%
29,123
-533
-2% -$31.9K
TFC icon
222
Truist Financial
TFC
$64B
$1.62M 0.01%
41,440
-5,416
-12% -$198K
IBM icon
223
IBM
IBM
$224B
$1.6M 0.01%
8,400
+116
+1% +$21.2K
NDSN icon
224
Nordson
NDSN
$17.3B
$1.6M 0.01%
5,838
PYPL icon
225
PayPal
PYPL
$50.5B
$1.59M 0.01%
23,725
-47
-0.2% -$2.88K

Similar funds

Bahl & Gaynor's Q1 2024 Portfolio in Review

As of Q1 2024, Bahl & Gaynor held 342 positions worth $18B, up 8% from $16.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor's Q1 2024 filing shows 16 new, 129 increased, 153 reduced and 4 closed positions. Its largest new stake was PPL Corp: 1,151,950 shares worth $31.7M. The largest sale was Regions Financial, an estimated $62.2M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q1 2024 buy was PPL Corp: 1,151,950 shares worth $31.7M.
  • Bahl & Gaynor added most to JPMorgan Chase in Q1 2024, an estimated $90.3M increase.
  • Bahl & Gaynor's biggest Q1 2024 reduction was Regions Financial, cutting an estimated $62.2M.
  • Bahl & Gaynor fully exited Johnson Controls International in Q1 2024, selling an estimated $23.6M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $18B portfolio in Q1 2024.
  • Bahl & Gaynor opened 16 new positions and closed 4 in Q1 2024.
  • Bahl & Gaynor's portfolio value rose 8% quarter-over-quarter to $18B.

Based on Bahl & Gaynor's 13F filing for Q1 2024, filed 10 May 2024.